<DOC>
	<DOCNO>NCT01173419</DOCNO>
	<brief_summary>This multi center , randomize , comparison study use two already clear method treatment great saphenous vein ( GSV ) . The hypothesis test use Venacure EVLT NeverTouch procedure bad RF ClosureFAST procedure treatment GSV . Evaluation post operative pain bruising , quality life assessment , adverse event assessment , confirmation long term GSV closure , use medication criterion evaluate course study .</brief_summary>
	<brief_title>Comparison Study Safety Efficacy Two Devices Treatment Great Saphenous Vein</brief_title>
	<detailed_description>Some form venous insufficiency affect 25 % men 40 % woman United States . While person seek treatment varicose vein unsightly , also experience symptom ache pain , night cramp , leg fatigue , leg heaviness leg restlessness . If leave untreated , nearly 50 % patient significant superficial venous insufficiency experience chronic venous insufficiency characterize low extremity swelling , eczema , pigmentation , hemorrhage ulceration . This multicenter , prospective , randomize study subject symptomatic venous insufficiency great saphenous vein . Subjects evaluated participation , prior first visit , elect receive invasive treatment GSV insufficiency already receive conservative treatment ( i.e . use compression hose ) . Subjects randomize receive one two method treatment . VenaCure EVLT NeverTouch method treatment RF ClosureFAST method treatment . Follow visit take place 2 , 7 , 14 30 day post treatment questionnaire ( SF-36 , CIVI Q2 , Visual Analogue Scale ) , evaluation GSV closure via duplex ultrasound ( 7 day 30 day ) , evaluation ecchymosis , physician ( designee ) evaluation venous disease ( CEAP assessment VCSS assessment ) , assessment adverse event review concomitant medication ( use analgesic medication ) take place . These evaluation exception use Visual Analogue Scale Ecchymosis evaluation also take place 6 month 12 month follow visit timepoints .</detailed_description>
	<mesh_term>Venous Insufficiency</mesh_term>
	<mesh_term>Varicose Veins</mesh_term>
	<criteria>male female , 18 80 year age , document symptomatic GSV disease define follow : C2 disease C3 disease C4A , C4B disease C5 disease C6 disease previously treat GSV , multilevel venous reflux great saphenous vein great 0.5 second distal compression/ release stand position , palpable dorsalis pedis/ anterior tibial pulse ABI &gt; 0.9 ( unless calcify pressure ) screening , able comply protocol requirement , able comprehend willing sign Informed Consent Form ( ICF ) . previous venous intervention leg plan current treatment , know hypercoagulable state , deep vein thrombosis history deep vein thrombosis , thrombus within last three month vein segment treat , aneurysmal section vein segment treat ( aneurysm define 2 time great adjacent vein ) , able ambulate , non stag adjunctive procedure sclerotherapy and/ ambulatory phlebectomy . May elect stage procedure initial script , treat 30 day follow visit complete . , opinion investigator , unable comply schedule protocol evaluation , currently pregnant breast feeding , know malignancy skin cancer , current use anticoagulant medication , condition opinion investigator could compromise subject safety adherence protocol , treatment investigational agent within 30 day visit 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Great Saphenous Vein</keyword>
</DOC>